Squamous cell carcinoma arising in long-standing hidradenitis suppurativa: An overlooked facet of the immunocompromised district

Clinics in Dermatology

Volumn 35, Issue 2, 2017, Pages 225-227

  Fabbrocini, Gabriella ^a   Ruocco, Eleonora ^b   De Vita, Valerio ^a   Monfrecola, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CARCINOGENESIS; DISEASE DURATION; EARLY DIAGNOSIS; EARLY INTERVENTION; GENE EXPRESSION REGULATION; HEALTH CARE COST; HUMAN; IMMUNE STATUS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INNATE IMMUNITY; LYMPHEDEMA; QUALITY OF LIFE; SQUAMOUS CELL SKIN CARCINOMA; SUPPURATIVE HIDRADENITIS; BUTTOCK; COMPLICATION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

BUTTOCKS; CARCINOMA, SQUAMOUS CELL; HIDRADENITIS SUPPURATIVA; HUMANS; IMMUNOCOMPROMISED HOST; SKIN NEOPLASMS;

EID: 85014491276     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2016.10.019     Document Type: Article

References (18)

1. [1] Menter, A., Recognizing and managing comorbidities and complications in hidradenitis suppurativa. Semin Cutan Med Surg 33 (2014), S54–S56.
2. [2] Saunte, D.M., Boer, J., Stratigos, A., et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol 173 (2015), 1546–1549.
3. [3] Verdelli, A., Antiga, E., Bonciani, D., et al. A fatal case of hidradenitis suppurativa associated with sepsis and squamous cell carcinoma. Int J Dermatol 55 (2016), e52–e53.
4. [4] Talmant, J.C., Bruant-Rodier, C., Nunziata, A.C., et al. Squamous cell carcinoma arising in Verneuil's disease: two cases and literature review. Ann Chir Plast Esthet 51 (2006), 82–86 [in French].
5. [5] Constantinou, C., Widom, K., Desantis, J., et al. Hidradenitis suppurativa complicated by squamous cell carcinoma. Am Surg 74 (2008), 1177–1181.
6. [6] Losanoff, J.E., Sochaki, P., Khoury, N., et al. Squamous cell carcinoma complicating chronic suppurative hydradenitis. Am Surg 77 (2011), 1449–1453.
7. [7] Pena, Z.G., Sivamani, R.K., Konia, T.H., et al. Squamous cell carcinoma in the setting of chronic hidradenitis suppurativa: report of a patient and update of the literature. Dermatol Online J, 21, 2015.
8. [8] Fimmel, S., Zouboulis, C.C., Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol 2 (2010), 9–16.
9. [9] Ruocco, V., Brunetti, G., Puca, R.V., et al. The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol Venereol 23 (2009), 1364–1373.
10. [10] Ruocco, V., Ruocco, E., Piccolo, V., et al. The immunocompromised district in dermatology: a unifying pathogenic view of the regional immune dysregulation. Clin Dermatol 32 (2014), 569–576.
11. [11] Lee, R., Saardi, K.M., Schwartz, R.A., Lymphedema-related angiogenic tumors and other malignancies. Clin Dermatol 32 (2014), 616–620.
12. [12] Faye, O., Petit, F., Poli, F., et al. Lymphedema as a complication of hidradenitis suppurativa in three patients. Ann Dermatol Venereol 134 (2007), 567–569 [in French].
13. [13] Scheinfeld, N., Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis. Dermatol Online J, 19, 2013, 18558.
14. [14] International Society of Lymphology, The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology 36 (2003), 84–91.
15. [15] International Society of Lymphology, The diagnosis and treatment of peripheral lymphedema. 2009 Consensus document of the International Society of Lymphology. Lymphology 42 (2009), 51–60.
16. [16] Carlson, J.A., Lymphedema and subclinical lymphostasis (microlymphedema) facilitate cutaneous infections, inflammatory dermatoses, and neoplasia: A locus minoris resistentiae. Clin Dermatol 32 (2014), 599–615.
17. [17] Baroni, A., Buommino, E., Piccolo, V., et al. Alterations of skin innate immunity in lymphedematous limbs: Correlation with opportunistic diseases. Clin Dermatol 32 (2014), 592–598.
18. [18] Piccolo, V., Baroni, A., Russo, T., et al. Ruocco's immunocompromised cutaneous district. Int J Dermatol 55 (2016), 135–141.